Lan Zhang

20080032404, Feb 7, 2008

Jul 19, 2007

11/780132

Frederick Roth - Newton MA, US
Oliver King - Somerville MA, US
Lan Zhang - San Francisco CA, US

President and Fellows of Harvard College - Cambridge MA

C12N 15/87

435440000

The present invention provides methods for engineering multiple genomic deletions and/or insertions in eukaryotic cells.

20090232283, Sep 17, 2009

Mar 14, 2008

12/048362

Lan Zhang - Wayne PA, US
Harry E. Blanchard - Rumson NJ, US
Steven H. Lewis - Middletown NJ, US
Gregory Pulz - Cranbury NJ, US

H04M 1/64

379 80

A method for determining a value for a call center, the value relating to an availability of the call center and setting a transfer strategy of an automated interactive voice response system based on the value. In addition, a system having a strategy adjustment module monitoring a call center and determining a value for the call center, the value relating to an availability of the call center and an automated response module setting a transfer strategy to transfer calls to the call center based on the value.

20100083360, Apr 1, 2010

Sep 30, 2008

12/242643

Lan Zhang - Malvern PA, US
Harry E. Blanchard - Rumson NJ, US
Steven H. Lewis - Middletown NJ, US
Gregory Pulz - Cranbury NJ, US

AT&T SERVICES, INC. - San Antonio TX

H04L 9/32
G06F 21/00

726 7, 726 5

In one aspect, a disclosed portable authentication device (PAD) includes a processor, storage media, an interface for enabling communication with an external information handling system (IHS), e.g., a computer or a telephony device, and executable instructions embedded in the storage media, for automated authentication. The embedded instructions include instructions for enabling a user to store authentication information, e.g., use ID and password information, corresponding to an IHS destination, e.g., a telephone number of an interactive voice response system or an IP address of a web server. If the PAD recognizes the current destination, the PAD may respond to an assertion of a keypad control element by making authorization information corresponding to the current destination available to the user or providing the authorization information directly to the current destination. The PAD may include one or more telephony interface(s), e.g., RJ-11 jack(s) and one or more computer interfaces, e.g., USB connector(s).

20210046173, Feb 18, 2021

Jan 28, 2019

16/965589

- Cambridge MA, US
Kapil Bahl - Medford MA, US
Amy Espeseth - Chalfont PA, US
Andrew J. Bett - Lansdale PA, US
Pedro Cejas - Oreland PA, US
Lan Zhang - Chalfont PA, US
Christine Shaw - Reading MA, US

ModernaTX, Inc. - Cambridge MA

A61K 39/12

The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

20200250582, Aug 6, 2020

Apr 20, 2020

16/853581

- Atlanta GA, US
Lan Zhang - Malvern PA, US
Gregory Pulz - Cranbury NJ, US

G06N 20/00
G10L 15/06
G10L 15/22

In one example, the present disclosure describes a device, computer-readable medium, and method for automatically learning and facilitating interaction routines involving at least one human participant. In one example, a method includes learning an interaction routine conducted between a human user and a second party, wherein the interaction routine comprises a series of prompts and responses designed to identify and deliver desired information, storing a template of the interaction routine based on the learning, wherein the template includes at least a portion of the series of prompts and responses, detecting, in the course of a new instance of the interaction routine, at least one prompt from the second party that requests a response from the human user, and using the template to provide a response to the prompt so that involvement of the human user in the new instance of the interaction routine is minimized.

20200069792, Mar 5, 2020

Apr 25, 2018

16/607412

Dai WANG - West Point PA, US
Lan ZHANG - West Point PA, US
- Rahway NY, US

Merck Sharp & Dohme Corp. - Rahway NJ

A61K 39/245
C12N 7/00
A61P 31/22
C07K 14/005

The disclosure relates to HSV glycoprotein B and HSV glycoprotein C antigenic peptide constructs, HSV protein vaccines, and HSV DNA vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

20200054737, Feb 20, 2020

Apr 25, 2018

16/608451

- Cambridge MA, US
Shinu John - Somerville MA, US
Andrew J. Bett - Lansdale PA, US
Danilo R. Casimiro - Harleysville PA, US
Dai Wang - Blue Bell PA, US
Lan Zhang - Chalfont PA, US

Modema TX, Inc. - Cambridge MA

A61K 39/245
A61K 9/51
C12N 7/00

The disclosure relates to herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

20200002407, Jan 2, 2020

Jun 7, 2019

16/434729

- Rahway NJ, US
KARA S. COX - HARLEYSVILLE PA, US
AIMIN TANG - LANSDALE PA, US
ZHIFENG CHEN - WARRINGTON PA, US
DANIEL DISTEFANO - HARLEYSVILLE PA, US
LAN ZHANG - CHALFONT PA, US

Merck Sharp & Dohme Corp. - Rahway NJ

C07K 16/10
A61K 39/42

The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.